Patients with Stage I-IIA CTCL must be at least 18 years of age with a skin biopsy prior to enrolment confirming the diagnosis of mycosis fungoides.
You may not be if
Patients with Stage \>IIA CTCL at the time of enrolment
Women who are pregnant or planning to get pregnant, or unable/unwilling to use adequate contraception
Patients who were treated with topical retinoid therapy in the past 3 months
Patients who received any systemic CTCL therapy or systemic corticosteroid therapy within 30 days of the study start date
Patients who were treated with systemic isotretinoin or bexarotene within 3 months prior to the study start date, systemic acitretin within 2 years prior to study start date
Clareo Health | Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study
